Puig Brands (PUIG) CMD 2026 summary
Event summary combining transcript, slides, and related documents.
CMD 2026 summary
3 Nov, 2026Vision 2032 and track record
By 2032, targets are >€8bn net revenue, >22.5% adjusted EBITDA margin and growth ahead of the premium beauty market’s expected 4%-5% CAGR; growth is primarily organic.
Aspires to rank among the world’s top four premium beauty players and become the #2 fragrance player by 2032.
FY21-25 revenue CAGR was 18%, reaching €5.042bn in FY25; FY25 LFL growth was 7.8% versus 3.4% for the premium beauty market.
FY25 adjusted EBITDA margin was 20.7%; the 2032 ambition implies >180 bps expansion and adjusted EBITDA above €1.8bn.
After the 2025-26 market reset, 2027 growth is expected near the lower end of the 4%-5% market range, with gradual improvement thereafter.
Portfolio and brand priorities
Reinforce prestige fragrance through Carolina Herrera, Rabanne and Jean Paul Gaultier; the 2032 ambition is a top-two global position, supported by innovation and global activation.
Grow Byredo and Penhaligon’s through existing-door productivity and selective expansion; niche fragrance targets €1bn by 2032 and growth twice as fast as the market.
Develop Charlotte Tilbury as a tri-axis brand across makeup, skincare and fragrance; the 2032 plan targets 1.5x growth, with fragrance acceleration from 2028.
Build a global Dermo-Cosmetics platform with ISDIN, Uriage and Apivita; Uriage targets doubling by 2032, while the platform would exceed €1bn pro forma net revenue subject to ISDIN completion.
Profitable growth and portfolio focus take priority; selective acquisitions may add distinctive brands, capabilities or exposure to attractive categories and markets.
Markets and growth opportunities
Consolidate EMEA and Travel Retail, reinforce Latin America, scale profitably in the US and build APAC; APAC was 11% of FY25 sales versus 39% of the global beauty market.
APAC sales grew 22% in 2025 and 18% year-to-date 2026; expansion is staged and profitability-led.
Digital, APAC, US niche fragrance, feminine prestige fragrance, Charlotte Tilbury distribution and Dermo-Cosmetics are identified growth whitespace areas.
US niche expansion is a priority; the US represents 25% of the niche market versus 14% of portfolio niche weight, with selective door growth planned.
Travel Retail rose from the sixth- to third-largest fragrance player since 2021, with share increasing from 9.6% to 13.0%.
Latest events from Puig Brands
- Q3 growth accelerated as Makeup and APAC led; FY outlook reaffirmed.PUIG
Q3 2026 TU - Net revenues rose 2.4% to €2.35bn, with strong Asia Pacific growth and higher Charlotte Tilbury stake.PUIG
H1 2026 - Q1 2026 net revenue grew 4.7% LFL, led by APAC and Makeup, with stable outlook and merger talks ongoing.PUIG
Q1 2026 TU - Record revenue, margin expansion, and strong cash flow drive robust 2025 performance.PUIG
H2 2025 - 7.0% LFL revenue growth in 9M 2025, led by APAC and Makeup, with FY2025 outlook reaffirmed.PUIG
Q3 2025 TU - Q3 net revenue up 11.6% like-for-like, led by fragrance and strong EMEA and Americas growth.PUIG
Q3 2024 TU - H1 2024 revenue up 9.6% to €2.2bn, strong margins, IPO completed, and robust H2 outlook.PUIG
H1 2024 - Double-digit FY2024 growth led by fragrances, with record sales and market share gains.PUIG
Q4 2024 TU - Record revenue, margin, and profit growth in 2024; 2025 outlook targets 6–8% growth amid risks.PUIG
H2 2024